Edit |   |
---|---|
Antigenic Specificity | IFNA1, Human (Sifalimumab biosimilar) |
Clone | Sifalimumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IFNA1 Recombinant Antibody (Sifalimumab). Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a. Sifalimumab was developed by MedImmune, as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials. |
Immunogen | n/a |
Other Names | Anti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab, Anti-Human IFNA1 Recombinant Antibody(Sifalimumab), MDX-1103, MEDI-545, Antibody Drug Analogues, Monoclonal Antibody, YR1217, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1006877-41-3 |
Catalog # | YR1217 |
Price | please inquire |
Order / More Info | IFNA1, Human (Sifalimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |